Today we officially introduced Dr. Jonathan Simone, PhD as the Company’s Director of Research and Clinical Studies. Dr. Simone joined Aphria in July 2018 and serves as the primary liaison between the Company’s science, technical and medical division teams and outside medical, academic and clinical centers. He is also spearheading Aphria’s participation in various clinical studies.
Jonathan is a rising star in the medical cannabis research community and we are pleased to welcome him to the Aphria family. He is uniquely qualified to accelerate Aphria’s support for and participation in medical cannabis clinical research to further the Company’s continued global leadership in medical cannabis. Dr. Jonathan would like to take this opportunity to say a few words to the Aphria family:
“It is with great pleasure that I introduce myself to you as Aphria’s new Director of Research and Clinical Studies. I am thrilled to be joining the Aphria team, and to be part of an organization that is leading the global medical cannabis industry through their uncompromising commitments to quality, integrity, accountability, and above all else, a dedication to the well-being of their patients.
In my new role as Aphria’s Director of Clinical Research, I commit to advocating on your behalf, and to ensuring that the high standard of excellence you have come to expect from Aphria extends to our clinical research program. With your health and well-being as my top priority, I commit to advancing the field of medical cannabis science to ensure that you receive the highest quality and most effective medicine possible. And I assure you, we have hit the ground running.
Through rigorous, high-quality research collaborations with world-class medical and academic partners, we are working tirelessly on your behalf to generate new cannabis knowledge, to drive new product innovation, and most importantly, to validate the use of cannabis as medicine. Though still in its infancy, the future of the medical cannabis industry is bright and full of possibilities. At Aphria, we are dedicated to that future and to ensuring that we never stop working towards the goal of improving the quality of life of our patients. I hope that you are as excited as I am for what lies ahead. So stay tuned, because we have a good thing growing.”
— Dr. Jonathan Simone, Director of Research and Clinical Studies – PhD, Neurobiology and Physiology
Dr. Simone recently completed his PhD in Neurobiology and Physiology at Brock University in St. Catharines, Ontario where he was instrumental in the development of an award-winning, multi-disciplinary cannabinoid research program. His research into the neurobiology and behavioural pharmacology of cannabinoids and the endocannabinoid system has been recognized both nationally and internationally with awards from organizations including the Canadian Consortium for the Investigation of Cannabinoids (CCIC), the International Cannabinoid Research Society (ICRS), the Natural Sciences and Engineering Research Council of Canada(NSERC), and the Canadian College of Neuropsychopharmacology (CCNP), Dr. Simone’s research has been consistently published in high-quality, peer-reviewed scientific journals and presented at scientific conferences around the world. In July 2018, his research into the role of the endocannabinoid system in social behaviour development was awarded the Scientific Achievement Award at the 28th Annual ICRS Symposium on the Cannabinoids in Leiden, Netherlands.